• India has the highest number of USFDA-approved plants outside USA 

  • Indian healthcare market is the world's second-fastest growing with a market of US$65 billion growing at 15% CAGR 

  • India's medical tourism sector is growing at a rate of 30%, making it a $2 billion industry by 2015. 



The illustrative examples from the portfolio are as under:

Intas Biopharmaceuticals Ltd.

Intas Biopharmaceuticals, set up in year 2000 originally as an independent biotechnology company, is presently merged with the parent company Intas Pharmaceuticals Ltd. It was India¿s first biotechnology company to receive European Union- Good Manufacturing Practice (EU-GMP) certification for its manufacturing facility in 2007.

Presently, Intas Biologics has an extensive product portfolio of biosimilars across microbial and mammalian cell culture. Its products include Neukine® (GCSF), Erykine® (EPO), Intalfa® (IFN), Pegasta® (Peg GCSF), Terifrac® (Teriparatide), Mabtas® (Rituximab), Folisurge® (FSH). In addition to the EU-GMP, the facilities are presently approved by various other regulatory agencies such as ANVISA, GCC, MCC, Indonesia, etc.

Industry             : Pharmaceuticals

Transaction Date : May 2010

Website             : http://www.intaspharma.com/


Novalead Pharma

Novalead Pharma is a research company focused on discovery of new indications for existing drugs leveraging its in-house proprietary technology platform. Novaleads Drug Repositioning model offers a risk mitigated approach for discovering novel patent protected drugs.

Lead candidate GalnobaxTM for diabetic foot ulcer has successfully completed Phase I/IIa proof of concept global clinical trials. GalnobaxTM addresses a significant global unmet medical need with market size estimated well in excess of US$2 bn. Novalead is also working on a new indication pipeline of ten molecules across five disease areas.

Industry             : Pharmaceuticals

Transaction Date : August 2010

Website             : http://www.novaleadpharma.com


Amanta Healthcare Limited

Amanta Healthcare is among India's leading manufacturers of sterile liquid dosages. The Company has a diverse product portfolio spanning Fluid Therapy, Ophthalmic, Respiratory, Eye & Wound Irrigation Solution, Critical Care, Injectables & Diluents. Amanta has a strong domestic market presence and exports to over 77 countries directly and through contract manufacturing.

Amanta is the first company in India to launch a novel IV fluid container- Steriport, which has advantage over existing products in terms of sterility, closure & transparency.

The Company has ISO certified & WHO GMP compliant manufacturing facilities at Gujarat and Goa, which are also accredited by TGA (Australia) among others.

Industry             : Pharmaceuticals

Transaction Date : December 2012

Website             : http://amanta.co.in/



Sandor Nephro Services Pvt. Ltd

Sandor Nephro operates India¿s second largest chain of dialysis centres under the brand - Sparsh Nephrocare. The company is a pioneer of in-hospital dialysis centres in India and has a pan India network of 50+ centres across 12 states.

Sandor's focus is on improving accessibility and affordability for dialysis patients through partnerships with nephrologists, government/private hospitals and medical institutes in Tier II/ Tier III locations.

Industry             : Single Specialty Healthcare Delivery

Transaction Date : March 2014

Website             : http://www.sandor.co.in



Lokmanya Hospitals Pvt. Ltd

Lokmanya Hospitals is a chain of multi-specialty hospitals in Maharashtra and currently operates 250 beds across five locations. Lokmanya's core focus is trauma and full spectrum orthopedic surgeries like joint replacements, arthroscopy and spine surgeries.

As of December 2015, Lokmanya has completed 5,000+ joint replacements and 1,50,000+ Orthopedic surgeries. Lokmanya also caters to international patients through focused marketing effort in the MENA region.

Industry             : Single Specialty Healthcare Delivery

Transaction Date : March 2014

Website             : http://www.lokmanyahospitals.in/



Shriji Polymers (India) Limited

Shriji Polymers is the largest Indian manufacturer of primary packaging products for export of generic drugs to US and Canada. Shriji's product portfolio includes varieties of caps and closures, HDPE bottles, multilayer bottles, Child Resistant Closures and Applicator Devices.

The Company enjoys a sticky and diverse customer base and is the only Indian company to have a US patent for Child Resistant closures. Shriji's operations span across India, China and the US.

Industry             : Pharmaceutical Packaging

Transaction Date : October 2015

Website             : http://www.packingpeople.com/



Sai Lifesciences Limited

Sai Lifesciences is an integrated drug discovery, development and formulation services company. Sai's core expertise is synthetic, medicinal and process chemistry which is further augmented by its suite of preclinical support services.

Sai's customer base includes marquee global innovator and generic companies. Sai has GMP compliant facilities (USFDA Certified) around Hyderabad and Pune. The Process research and development segment along with commercial manufacturing segment constitute the main parts of the business.

Industry             : Pharmaceutical

Transaction Date : November 2015

Website             : http://www.sailife.com


Brinton Pharmaceuticals

Brinton Pharmaceuticals is India's fastest growing dermatology formulations company as per AIOCD market research dated March 2017. The company offers a full spectrum portfolio of clinical and cosmetic dermatology formulations in therapy areas such as anti-fungals, topical corticosteroids, anti-acne, skin care emollients, and hair care.

Brinton has a specialized field force of 240 medical representatives servicing over 6000 dermatologists across 28 states in India. Within three years of inception, the company has five brands that are ranked amongst top five within their respective therapeutic categories (Source: AWACS Research).

Industry             : Pharmaceuticals (Domestic Formulations)

Transaction Date : March 2017

Website             : http://www.brintonhealth.com/


Konverge Healthcare Private Ltd

Konverge Healthcare is a fast growing domestic formulations company with focus on therapeutic categories such as Gynaecology, Orthopaedics, Neutraceuticals and Lifestyle segments. The company has a focussed approach on therapy leadership through identified brands having high volume, and repeat purchase potential.

Within few years of inception, Konverge has built a presence in thirteen states having a KOL (Key Opinion Leader) focused marketing strategy. The company has a field force of 200 medical representatives reaching out to over 30,000 doctors across the country.

Industry             : Pharmaceuticals (Domestic Formulations)

Transaction Date : March 2017

Website             : http://www.konvergehealthcare.com



Tata Capital Private Equity has engaged CAMS - a professionally managed, institutionally owned and SEBI regulated IT services solution partner to provide investor related accounting services.

To log in to your CAMS Online Account, click here


Fund in the news
  • Tata Capital Healthcare Fund plans Fund II in 2016 Know more
  • Tata Capital Healthcare Fund looking to raise second fund next year Know more
Portfolio News & Articles
  •   Robotic technique all set to be a game changer in knee surgeries Know more
  •   56-yr-old undergoes rare robotic knee replacement surgery in city Know more
  •   Phase I/II trials for DFU potential drug successful: NovaLead Know more
  •   NovaLead Pharma to launch drug for diabetic foot ulcer Know more